Documentos relacionados

1. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.
2. Ankaferd blood stopper decreases postoperative bleeding and number of transfusions in patients treated with clopidogrel: a double-blind, placebo-controlled, randomized clinical trial.
3. Safety of Continued Clopidogrel Use in the Preoperative Course of Gastrointestinal Surgery: A Retrospective Cohort Study.
4. Prasugrel increases the need for platelet transfusions and surgical reexploration rates compared with clopidogrel in coronary artery bypass surgery.
5. Complications of hip fracture surgery on patients receiving clopidogrel therapy.
6. Perioperative clopidogrel is associated with increased bleeding and blood transfusion at the time of lower extremity bypass.
7. A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting.
8. [Effectiveness and safety of tranexamic acid in patients receiving on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation].
9. Risk factors for re-exploration due to bleeding after coronary artery bypass grafting.
10. Bleeding outcomes in patients given clopidogrel within 5 days of robotic coronary artery bypass graft procedure.